24/7 Patient Assistance: 760-405-8205

David Kornguth, MD

Radiation Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

specialties & services

  • Bio & Insurance Information

    Dr. David Kornguth graduated the medical school from the Boston University. He did his internship at the University of Texas Health Science Center and completed his residency program at the University of Texas MD Anderson Cancer Center. He is specialized in Radiation Oncology and board certified in Diagnostic Radiology and Radiation Oncology. Dr. Kornguth has been in practice for more than 11 years and is affiliated with the Chinese Hospital. During his career, he has also contributed to 9 publications of medical interest.



  • Education & Training

    dept_icon

    Boston University

    Medical School

    dept_icon

    University of Texas Health Science Center

    Internship

    dept_icon

    University of Texas MD Anderson Cancer Center

    Residency

  • Board Certifications

    American Board of Radiology - Diagnostic Radiology

  • Hospital & Practice

    San Francisco Chinese Hospital

    Languages: English/Spanish

    (415) 982-2400

    845 Jackson St

    San Francisco, California 94133

    Read More
  • Publications & Memberships

    Dr. David Kornguth has contributed to 3 publications.

    Optimal treatment planning for skull base chordoma: photons, protons, or a combination of both?

    Torres, M.A., Chang, E.L., Mahajan, A., Lege, D.G., Riley, B.A., Zhang, X., Lii, M., Kornguth, D.G., Pelloski, C.E., Woo, S.Y.; Int J Radiat Oncol Biol Phys. 2009-07-15.

    See more >>

    Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma.

    Scheurer, M.E., Amirian, E., Cao, Y., Gilbert, M.R., Aldape, K.D., Kornguth, D.G., El-Zein, R., Bondy, M.L.; Clin Cancer Res. 2008-10-15.

    See more >>

    Multimodality treatment of osteosarcoma: radiation in a high-risk cohort.

    Mahajan, A., Woo, S.Y., Kornguth, D.G., Hughes, D., Huh, W., Chang, E.L., Herzog, C.E., Pelloski, C.E., Anderson, P.; Pediatr Blood Cancer. 2008 May.

    See more >>